Publication | Closed Access

Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma

Cell-based Drug DeliveryNanomedicineNeuro-oncologyTumor ImmunologyRadiation OncologyTumor-derived ExosomesDendritic Cell-based ImmunotherapyTargeted Drug DeliveryImmunologyTherapeutic VaccineTumor TargetingImmunotherapyMedicineGliomaHealth Sciences